Threatened Abortion

1. Comprehensive Executive Overview

In the field of obstetrics and gynecology (أمراض النساء والتوليد), a Threatened Abortion (classified under ICD-10 code O20.0) is defined as vaginal bleeding occurring before the 20th completed week of gestation in the presence of a closed internal cervical os.

It is crucial to clarify a common point of confusion for patients: in clinical terminology, the word "abortion" refers to any pregnancy loss or threatened loss before viability, and does not imply a voluntary or elective termination of pregnancy. A threatened abortion is essentially a "threatened miscarriage."

  [Early Pregnancy Bleeding (< 20 Weeks)]
                    │
        ┌───────────┴───────────┐
 [Cervical Os CLOSED]    [Cervical Os OPEN]
        │                       │

[Threatened Abortion] [Inevitable/Incomplete]

Epidemiology and Significance

• Prevalence: Approximately 15% to 20% of clinically recognized pregnancies experience vaginal bleeding during the first trimester.
• Resolution Rate: Thankfully, about 50% of women who experience a threatened abortion go on to have a successful, full-term pregnancy. The remaining 50%, unfortunately, progress to spontaneous pregnancy loss (spontaneous abortion).
• Clinical Urgency: While common, any first-trimester bleeding requires immediate, systematic clinical evaluation to rule out life-threatening conditions such as an ectopic pregnancy or a molar pregnancy.

2. Detailed Pathophysiology, Etiology, and Risk Factors

Pathophysiology

The physiological mechanism of a threatened abortion typically begins with a disruption at the maternal-fetal interface.

1. Choriodecidual Hemorrhage: Localized bleeding occurs within the decidua basalis (the maternal endometrium during pregnancy). This bleeding separates the decidual membrane from the chorionic villi.
2. Subchorionic Hematoma: If the hemorrhage dissects along the chorionic membrane, it forms a subchorionic hematoma (an accumulation of blood between the uterine wall and the chorionic membrane).
3. Uterine Irritability: The presence of extravasated blood acts as a local irritant, triggering localized inflammatory cascades, prostaglandin release, and subsequent mild uterine contractions. This presents clinically as pelvic cramping.
4. Placental Dysfunction: If the separation is extensive, it compromises the exchange of oxygen and nutrients between the mother and the developing embryo, potentially leading to embryonic demise.

+-------------------------------------------------------------+
| PATHOPHYSIOLOGICAL CASCADE |
| |
| Decidual Hemorrhage -> Subchorionic Hematoma -> |
| Prostaglandin Release -> Uterine Contractions -> Pain |
+-------------------------------------------------------------+

Etiology

The causes of a threatened abortion can be broadly categorized into fetal, maternal, and paternal factors:

Risk Factors

Several clinical and demographic variables increase a patient's risk of experiencing a threatened abortion:
* Advanced Maternal Age: Women over 35 have a significantly higher rate of chromosomal anomalies in oocytes, leading to higher rates of threatened and spontaneous abortion.
* Prior Pregnancy Loss: A history of previous miscarriages increases the baseline risk.
* Exogenous Toxins & Lifestyle: Active smoking, moderate-to-high alcohol consumption, high caffeine intake (>200 mg daily), and recreational drug use.
* Medications: Recent use of nonsteroidal anti-inflammatory drugs (NSAIDs) around the time of conception.
* Obesity: A body mass index (BMI) greater than 30 kg/m² is associated with higher rates of early pregnancy complications.

3. Signs, Symptoms, and Clinical Presentation

The clinical presentation of a threatened abortion is characterized by a specific constellation of signs and symptoms. Recognizing these early is vital for appropriate triage and management.

Primary Presentation

• Vaginal Bleeding: This is the hallmark symptom. The bleeding can range from light spotting or brownish discharge to active, bright red bleeding. It may occur intermittently or continuously for several days.
• Abdominal/Pelvic Pain: Patients often describe a dull, aching pain in the lower abdomen, pelvic pressure, or mild menstrual-like cramping. The pain is typically midline and may radiate to the lower back.

Key Clinical Distinctions

To classify the condition accurately as a threatened abortion, the following clinical features must be met during a physical examination:

• Closed Cervical Os: Upon sterile speculum examination, the external and internal cervical ostia must be completely closed. No fetal or placental tissue should be visible within the cervical canal.
• Uterine Size: The uterus should be appropriate for the calculated gestational age.
• Absence of Tissue Passage: The patient must not have passed any solid tissue (decidua or products of conception) from the vagina.

Differential Diagnosis Checklist

Clinicians must actively rule out other potential causes of first-trimester bleeding:
* Ectopic Pregnancy: A life-threatening condition where the embryo implants outside the uterine cavity (usually in the fallopian tube). Characterized by unilateral pelvic pain and abnormal beta-hCG tracking.
* Inevitable Abortion: Bleeding and cramping accompanied by a dilated cervical os, indicating that pregnancy loss is certain to occur.
* Incomplete Abortion: Partial expulsion of the products of conception through a dilated cervix.
* Molar Pregnancy (Gestational Trophoblastic Disease): Abnormal proliferation of trophoblastic tissue, often presenting with extremely high beta-hCG levels and a "snowstorm" pattern on ultrasound.
* Local Cervical/Vaginal Pathology: Cervical polyps, severe vaginitis, or cervical ectropion, which can bleed easily upon contact (e.g., after intercourse).

4. Standard Diagnostic Evaluation & Workup

A comprehensive diagnostic workup is essential to confirm the diagnosis of threatened abortion, evaluate fetal viability, and rule out ectopic or non-viable gestations.

                [Patient with First-Trimester Bleeding]
                                   │
                  ┌────────────────┴────────────────┐
         [Physical Exam]                     [Lab Assays]
    (Speculum: Closed Cervical Os)       (Beta-hCG, Rh Status)
                                   │
                                   ▼
                   [Transvaginal Ultrasound (TVUS)]
                                   │
         ┌─────────────────────────┼─────────────────────────┐
         ▼                         ▼                         ▼
[Intrauterine Sac +       [Empty Uterine Cavity]     [Subchorionic Hematoma]

Fetal Cardiac Activity] │ │
│ [Evaluate for Ectopic] [Monitor Size & Impact]
(Threatened Abortion)

1. Imaging: Transvaginal Ultrasonography (TVUS)

TVUS is the gold standard imaging modality for evaluating early pregnancy bleeding. It provides high-resolution visualization of the uterine cavity.

• Fetal Cardiac Activity: The presence of a visible fetal heartbeat (typically detectable when the embryonic crown-rump length is $\ge 7\text{ mm}$) confirms a viable intrauterine pregnancy.
• Gestational Sac & Yolk Sac Evaluation: Evaluates the placement, size, and shape of the gestational sac. An irregular sac shape or an abnormally large yolk sac (>6 mm) can indicate a guarded prognosis.
• Subchorionic Hematoma Identification: TVUS can identify and measure the volume of a subchorionic collection. Large hematomas (occupying >50% of the gestational sac circumference) carry a higher risk of progressing to pregnancy loss.

2. Laboratory Assays

• Quantitative Serial Beta-hCG ($\beta$-hCG):
• In a healthy early pregnancy, serum $\beta$-hCG levels should approximately double every 48 to 72 hours.
• In a threatened abortion, $\beta$-hCG levels may continue to rise normally. A plateauing or declining level suggests a non-viable pregnancy (missed or incomplete abortion).
• The Discriminatory Zone: This is the $\beta$-hCG level (usually between 1,500 and 2,000 mIU/mL) above which a normal intrauterine gestational sac must be visible via TVUS. If $\beta$-hCG is above this zone and no sac is seen, ectopic pregnancy must be highly suspected.
• Serum Progesterone:
• Progesterone is vital for maintaining the decidua.
• Levels $> 25\text{ ng/mL}$ are highly associated with viable intrauterine pregnancies.
• Levels $< 5\text{ ng/mL}$ indicate a non-viable pregnancy, regardless of location.
• Complete Blood Count (CBC): To assess the severity of blood loss (hemoglobin and hematocrit levels) and rule out an infectious process (white blood cell count).
• Blood Type and Rh Factor Screening: Essential to determine if the patient is Rh-negative. If so, they are at risk of Rh isoimmunization if fetal-maternal hemorrhage occurs.

5. Therapeutic Interventions & Clinical Management

The management of a threatened abortion is primarily supportive and expectant, as there are limited interventions that can stop an inevitable miscarriage caused by genetic anomalies. However, evidence-based protocols exist to optimize outcomes for viable pregnancies.

Pharmacotherapy

• Progesterone Supplementation:
• Progesterone relaxes the myometrium and modulates the local maternal immune response.
• Clinical Evidence: Large-scale clinical trials (such as the PRISM Trial) have shown that in women with a history of one or more previous miscarriages who present with vaginal bleeding in early pregnancy, the administration of vaginal progesterone (e.g., micronized progesterone 400 mg twice daily) significantly increases the rate of live births.
• Rho(D) Immune Globulin (RhoGAM):
• Administered to all Rh-negative, unsensitized women presenting with a threatened abortion to prevent alloimmunization.
• The standard microdose (50 mcg) is typically sufficient in the first trimester (before 12 weeks), while a standard dose (300 mcg) is used after 12 weeks of gestation.
• Analgesics:
• For pain management, Acetaminophen (Paracetamol) is the preferred agent.
• NSAIDs (such as Ibuprofen) are strictly contraindicated as they inhibit prostaglandin synthesis, which can interfere with normal implantation and uterine vascular tone.

Surgical Interventions

• No Surgical Indications: There are no surgical interventions indicated for a threatened abortion while the fetus remains viable and the cervix remains closed.
• Note: If the condition progresses to an incomplete, inevitable, or missed abortion, medical management (Misoprostol) or surgical evacuation (Uterine Aspiration/Dilation and Curettage) may then be discussed.

Lifestyle and Supportive Care

• Pelvic Rest: Patients are strongly advised to avoid sexual intercourse, douching, and the use of tampons until the bleeding has completely resolved for at least 48 hours. Pelvic rest prevents mechanical stimulation of the cervix and reduces the risk of ascending infections.
• Activity Modification: While strict, absolute bed rest has not been clinically proven to prevent miscarriage, modified activity (avoiding heavy lifting, strenuous exercise, and prolonged standing) is widely recommended to minimize physical stress and promote pelvic perfusion.
• Psychological Support: Experiencing early pregnancy bleeding is highly stressful. Providing empathetic counseling, clear explanations of statistics, and access to support groups is a fundamental component of holistic clinical care.

6. Frequently Asked Questions (FAQs)

1. What is the difference between a threatened abortion and a miscarriage?

A threatened abortion is an early pregnancy complication characterized by vaginal bleeding while the fetus is still alive and the cervix remains closed. It represents a risk of miscarriage. A miscarriage (spontaneous abortion) is the actual, completed loss of the pregnancy, where the fetus is no longer viable or has been expelled from the uterus.

2. Can a threatened abortion be stopped or prevented?

If the threatened abortion is caused by chromosomal abnormalities in the embryo (which is the case in over half of all early losses), it cannot be stopped. However, if the pregnancy is genetically normal, supportive measures such as progesterone therapy (especially in women with a history of recurrent miscarriages), pelvic rest, and avoiding strenuous activity can help support the pregnancy to term.

3. How long does the bleeding from a threatened abortion typically last?

The duration of bleeding varies widely. It can range from a few days of light spotting to several weeks of intermittent, light-to-moderate bleeding. Any increase in the volume of bleeding or the passage of clots should be reported to your obstetrician immediately.

4. Is strict bed rest mandatory for treating a threatened abortion?

Historically, strict bed rest was routinely prescribed. However, modern clinical studies have shown that absolute bed rest does not change the ultimate outcome of the pregnancy and can increase the risk of blood clots (deep vein thrombosis). Instead, doctors now recommend "modified activity"—avoiding strenuous exercise, heavy lifting, and long hours on your feet, while continuing light, daily movements.

5. Does having a subchorionic hematoma cause a threatened abortion?

Yes, a subchorionic hematoma (blood pooling between the uterine wall and the pregnancy sac) is a very common cause of threatened abortion symptoms, particularly vaginal bleeding. While many small hematomas resolve on their own without harming the pregnancy, larger hematomas require careful monitoring via ultrasound as they carry a higher risk of complications.

6. When should I go to the emergency room for early pregnancy bleeding?

You should seek emergency medical care immediately if you experience:
* Heavy vaginal bleeding (soaking through more than one sanitary pad per hour).
* Severe, sharp, or one-sided abdominal or pelvic pain.
* Dizziness, fainting, extreme lightheadedness, or confusion.
* Fever, chills, or foul-smelling vaginal discharge.
* Passage of tissue or large blood clots.

7. Can emotional stress cause a threatened abortion?

Normal, everyday emotional stress, anxiety, or a sudden fright do not cause a threatened abortion or a miscarriage. While chronic, severe physical stress can affect overall health, early pregnancy bleeding is almost always related to chromosomal, hormonal, or anatomical factors rather than emotional state.

8. What level of progesterone is considered normal during a threatened abortion?

In early pregnancy, a serum progesterone level above $25\text{ ng/mL}$ is highly reassuring and indicates a strong, viable pregnancy. Levels between $5\text{ and }20\text{ ng/mL}$ are intermediate and may prompt your doctor to prescribe progesterone supplements. A progesterone level below $5\text{ ng/mL}$ is highly suggestive of a non-viable pregnancy.

9. Will a threatened abortion affect my baby's health if the pregnancy continues?

If the bleeding resolves and the pregnancy continues, the vast majority of babies are born perfectly healthy. However, clinical studies indicate that women who experience first-trimester bleeding have a slightly higher baseline risk of late-pregnancy complications, such as preterm labor, low birth weight, or placental abruption. Consequently, these pregnancies are monitored with extra care.

10. How is a threatened abortion coded under ICD-10?

In medical records and insurance billing, a threatened abortion is classified under the specific diagnostic code ICD-10: O20.0. This code falls under the category of "Hemorrhage in early pregnancy" and is used strictly when the cervix remains closed during early pregnancy bleeding.

Related Clinical Integration

In the management of a threatened abortion, the primary clinical objective is to stabilize the pregnancy and mitigate the risk of spontaneous miscarriage through evidence-based interventions. When clinical assessment confirms a viable intrauterine pregnancy, progesterone supplementation is frequently indicated to support the decidual environment and reduce uterine contractility. In this context, Proluton Depot / برولوتون ديبو 250 mg/mL serves as a critical pharmacological intervention, providing sustained progestogenic support to patients presenting with vaginal bleeding and documented fetal cardiac activity. By integrating Proluton Depot / برولوتون ديبو 250 mg/mL into the therapeutic protocol, clinicians can effectively standardize care pathways, ensuring that patients receive timely hormonal stabilization while undergoing close monitoring for further pregnancy complications.